Kimia Biosciences Ltd

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced the 33rd Annual General Meeting (AGM) to be held on September 28, 2026, through video conferencing. The meeting will discuss the company's financial year 2025-26 annual report and other business matters.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced the outcome of its Board of Directors meeting held on September 3, 2026, where the board considered and approved various matters, including the re-appointment of directors, appointment of new directors, and approval of remuneration for cost auditors and other matters.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has published unaudited financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with a profit of Rs. 35.58 crores and earnings per share of Rs. 0.08.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with revenue from operations at ₹2,072.25 crore and profit for the period at ₹35.58 crore.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve Un-Audited Financial Results for the first quarter ended on June 30th, 2026.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced the appointment of new auditors, including a cost auditor, internal auditor, and secretarial auditor, and the discontinuance of the previous secretarial auditor. The appointments are effective from August 1, 2026.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced the appointment of new auditors, including a cost auditor, internal auditor, and secretarial auditor, and the discontinuance of the current secretarial auditor.